MAP9

Chr 4

microtubule associated protein 9

Also known as: ASAP

MAP9 encodes ASAP, a microtubule-associated protein that is required for bipolar spindle assembly, mitotic progression, and cytokinesis. Mutations cause autosomal recessive primary microcephaly, with affected individuals showing severe intellectual disability and developmental delays from early infancy. The gene shows very high constraint against loss-of-function variants, indicating its critical importance for cellular function.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
1
Pubs (1 yr)
29
P/LP submissions
0%
P/LP missense
1.19
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryMAP9
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
29 unique Pathogenic / Likely Pathogenic· 82 VUS of 130 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.19LOEUF
pLI 0.000
Z-score 0.74
OE 0.85 (0.621.19)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.16Z-score
OE missense 0.97 (0.881.07)
288 obs / 295.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.85 (0.621.19)
00.351.4
Missense OE0.97 (0.881.07)
00.61.4
Synonymous OE0.99
01.21.6
LoF obs/exp: 25 / 29.3Missense obs/exp: 288 / 295.5Syn Z: 0.08
DN
0.7132th %ile
GOF
0.6442th %ile
LOF
0.3746th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

130 submitted variants in ClinVar

Classification Summary

Pathogenic25
Likely Pathogenic4
VUS82
Likely Benign6
25
Pathogenic
4
Likely Pathogenic
82
VUS
6
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
25
0
25
Likely Pathogenic
0
0
4
0
4
VUS
0
80
2
0
82
Likely Benign
0
5
1
0
6
Benign
0
0
0
0
0
Total085320117

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

MAP9 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →